[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
[ Wed, Aug 07th 2024 ]: WOPRAI
Mike Matson Maintained (VCYT) at Strong Buy with Increased Target to $31 on, Aug 7th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Mike Matson of Needham, Maintained "Veracyte, Inc." (VCYT) at Strong Buy with Increased Target from $27 to $31 on, Aug 7th, 2024.
Mike has made no other calls on VCYT in the last 4 months.
There is 1 other peer that has a rating on VCYT. Out of the 1 peers that are also analyzing VCYT, 0 agree with Mike's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mike
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $28 on, Monday, April 15th, 2024